DNA-programmed bispecific peptide assemblies for delivering cytotoxic payload to cells expressing EGFR and MET receptors

Key Points

• Enhanced efficacy observed in targeting EGFR and MET receptors in cancer therapy, improving treatment impact.
• Reported findings emphasize the rapid optimization of the strategy using bispecific peptide assemblies.
• This research outlines a method for developing targeted treatments by utilizing unique cell surface receptors.
• These results highlight the potential for improved specificity in cancer therapy using dual-targeting approaches.